LADUROT 0,5MG/0,4MG CPS DUR 90
Active ingredient: TAMSULOSIN A DUTASTERID
View notice details →
News topic
Current shortage notices for the ATC group ATC G04, structured by product, country and reporting period.
57 noticesThe 57 consolidated notices from Czechia, Belgium, Austria, Denmark, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Active ingredient: TAMSULOSIN A DUTASTERID
View notice details →Active ingredient: Solifenacin
View notice details →Active ingredient: Avanafil
View notice details →Active ingredient: SILDENAFIL
View notice details →Active ingredient: SILDENAFIL
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tamsulosin ,Solifenacin
View notice details →Active ingredient: SILDENAFIL
View notice details →Active ingredient: Solifenacin
View notice details →Active ingredient: Solifenacin ,Tamsulosin
View notice details →Active ingredient: Solifenacin ,Tamsulosin
View notice details →Active ingredient: Solifenacin ,Tamsulosin
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: TADALAFIL
View notice details →Active ingredient: Finasteride
View notice details →Active ingredient: Silodosin
View notice details →Active ingredient: Solifenacin
View notice details →Active ingredient: Solifenacin
View notice details →Active ingredient: Tamsulosin Hydrochloride
View notice details →Active ingredient: TOLTERODIN TARTRAT
View notice details →Active ingredient: SILDENAFIL CITRAT
View notice details →Active ingredient: TAMSULOSIN A DUTASTERID
View notice details →Active ingredient: Avanafil
View notice details →Active ingredient: Avanafil
View notice details →Active ingredient: Avanafil
View notice details →Active ingredient: Sildenafil
View notice details →Active ingredient: SOLIFENACIN
View notice details →Active ingredient: Dutasteride,Tamsulosin Hydrochloride
View notice details →Active ingredient: TADALAFIL
View notice details →Active ingredient: VARDENAFIL HYDROCHLORID TRIHYDRAT
View notice details →Active ingredient: Finasteride
View notice details →Active ingredient: Vibegron
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tamsulosin Hydrochloride
View notice details →Active ingredient: Vardenafil
View notice details →Active ingredient: TADALAFIL
View notice details →Active ingredient: Vardenafil
View notice details →Active ingredient: SILDENAFIL
View notice details →Active ingredient: TOLTERODIN TARTRAT
View notice details →Active ingredient: Solifenacin ; Tamsulosin
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Sildenafil
View notice details →Active ingredient: SILDENAFIL CITRAT
View notice details →Active ingredient: SILDENAFIL
View notice details →Active ingredient: Tolterodin (tolterodintartrat)
View notice details →Active ingredient: Terazosinhydrochlorid-Dihydrat
View notice details →Active ingredient: Terazosinhydrochlorid-Dihydrat
View notice details →Active ingredient: Terazosinhydrochlorid-Dihydrat
View notice details →Active ingredient: SILDENAFIL CITRAT
View notice details →Active ingredient: Tolterodin (Tolterodintartrat)
View notice details →Active ingredient: Tolterodin (Tolterodintartrat)
View notice details →Active ingredient: SILDENAFIL CITRAT
View notice details →Active ingredient: SOLIFENACIN
View notice details →Active ingredient: SOLIFENACIN
View notice details →